European families reveal MHC class I and II associations with autoimmune-mediated congenital heart block

Potent cytotoxic responses can be mediated by HLA-C both in the context of NK and CD8+ T cells recognition, but with low level cell surface expression and a more restricted peptide binding, this HLA distinguishes itself among the class I molecules.3 Interestingly, immunohistology of heart tissue of...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 77; no. 9; pp. 1381 - 1382
Main Authors Kyriakidis, Nikolaos C, Kockum, Ingrid, Julkunen, Heikki, Hoxha, Ariela, Salomonsson, Stina, Meneghel, Lauro, Ebbing, Cathrine, Dilthey, Alexander, Eronen, Marianne, Carolis, Sara De, Kiserud, Torvid, Ruffatti, Amelia, Kere, Juha, Meisgen, Sabrina, Wahren-Herlenius, Marie
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 01.09.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Potent cytotoxic responses can be mediated by HLA-C both in the context of NK and CD8+ T cells recognition, but with low level cell surface expression and a more restricted peptide binding, this HLA distinguishes itself among the class I molecules.3 Interestingly, immunohistology of heart tissue of fetuses deceased from CHB shows CD8+ T cells in the mononuclear cell infiltrates,4 indicating a direct role for HLA class I peptide presentation to CD8+ T cells in the disease pathogenesis. There are many reports of negative DRB1*13 associations in European populations with autoimmune diseases.6 We therefore hypothesise that the protective DRB1*13 association with CHB depends on a general mechanism of protection from inflammation shared among autoimmune diseases, and interpret the observed lack of significantly associated HLA alleles that increase susceptibility to CHB as consistent with the fact that the pathogenic CHB-initiating autoantibodies are generated in the mother. Funding The study was supported by grants from the Swedish Research Council, the Heart-Lung Foundation, the Stockholm County Council, Karolinska Institutet, the Swedish Rheumatism Association, the King Gustaf Vth 80-year Foundation and the Freemason’s in Stockholm Foundation for Children’s Welfare.
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0003-4967
1468-2060
1468-2060
DOI:10.1136/annrheumdis-2018-212953